EventsThe 1st International E-Conference on Antioxidants in Health and Disease
Published
This submission belongs to the session S2. Antioxidants in Chronic Disease: From Dietary Prevention to Therapeutic Intervention of the event The 1st International E-Conference on Antioxidants in Health and Disease
Published date
08 Dec, 2020
Citation
Taseer Ahmad, ‪Taous‬ Khan, Abdul Jabbar Shah, Tahira Tabassum, Sultan A. Almedhesh, Hamdan Al shehri Al, Alasmary Mohammed Yahia, Mater H. Mahnashi, Mohammed N. Alqahtani, Cardioprotective effect of juglone on isoproterenol-induced myocardial injury in SD rats, in Proceedings of The 1st International E-Conference on Antioxidants in Health and Disease, 1 December–15 December 2020, MDPI: Basel, Switzerland, doi: 10.3390/CAHD2020-08916
Share
Email
Facebook
Twitter
LinkedIn

Cardioprotective effect of juglone on isoproterenol-induced myocardial injury in SD rats

image
Tahira Tabassum 3
Mohammed N. Alqahtani 7
1. Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Pakistan
2. COMSATS University Islamabad, Abbottabad Campus, Pakistan
3. Department Pathology, Sargodha medical college, University of Sargodha, Sargodha, Pakistan
4. College of Medicine, Najran University, Najran, 1988, Saudi Arabia
5. College of Medicine, Internal Medicine Department, Najran University, Najran, 1988, Saudi Arabia
6. Department of Medicinal Chemistry, Pharmacy School, Najran University, Najran, 1988, Saudi Arabia
7. Ahad Rufaidah General Hospital, Abha-Ahad Rufaidah, 62219, Saudi Arabia
Abstract

Aims: Therapeutic and/or preventive interventions using phytochemical constituents for ischemic heart disease have gained considerable attention worldwide, mainly due to its antioxidant activity. This study investigated the cardioprotective effect and possible mechanism of juglone, a major constituent of Walnut tree, using isoproterenol (ISO)-induced myocardial infarction (MI) model in rats.

Methodology: Rats were pretreated for five (5) days with juglone (1, 3 mg/kg, i.p) and atenolol (1 mg/kg, i.p) in separate experiments before inducing myocardial injury by the administration of ISO (80 mg/kg, s.c) at an interval of 24 hrs for 2 consecutive days (4th and 5th day). The cardioprotective effect of juglone was confirmed through lead II electrocardiograph (ECG), the cardiac biomarkers (ALT, AST, CPK, CK-MB, LDH and cTnI) and histopathological study.

Results: The results of our present study suggest that prior administration of juglone proved to be effective as a cardioprotective therapeutic agent in reducing the extent of myocardial damage (induced by ISO) by fortifying the myocardial cell membrane, heart tissue architecture, preventing inflammation, edema, necrosis and also by normalizing cardiac marker enzymes (AST, ALT, CPK, CK-MB, LDH and cTnI). Conclusion: In conclusion, this study has identified phytochemical constituents: juglone as a potential cardioprotective agent.

Keywords
Myocardial infarction (MI)
Juglone
antioxidant
Isoproterenol
ECG
Cardiac marker enzymes
Histopathology
Manuscript
Therapeutic Evaluation of the potential mechanisms of Anti-inflammatory Activities of Fagara zanthoxyloides Leave Extract in Wistar Rats
Modulation of oxidative stress associated with experimentally-induced benign prostatic hyperplasia in rats by Zapoteca portoricensis root extracts